Lee, Y., Bae, K. J., Chon, H. J., Kim, S. H., Kim, S. A., & Kim, J. (2016). A Receptor Tyrosine Kinase Inhibitor, Dovitinib (TKI-258), Enhances BMP-2-Induced Osteoblast Differentiation In Vitro. Mol Cells.
Citação norma ChicagoLee, Yura, Kyoung Jun Bae, Hae Jung Chon, Seong Hwan Kim, Soon Ae Kim, and Jiyeon Kim. "A Receptor Tyrosine Kinase Inhibitor, Dovitinib (TKI-258), Enhances BMP-2-Induced Osteoblast Differentiation In Vitro." Mol Cells 2016.
MLA citiranjeLee, Yura, et al. "A Receptor Tyrosine Kinase Inhibitor, Dovitinib (TKI-258), Enhances BMP-2-Induced Osteoblast Differentiation In Vitro." Mol Cells 2016.
Opozorilo: Ti citati niso vedno 100% točni.